XM 研究
Technical Analysis – CHFJPY retreats after hitting new record high
CHFJPY climbed to new record highs last week
But got rejected and has retreated a little since
Overall trend remains overwhelmingly positive
CHFJPY rose to its highest levels in at least four decades last week, since official records began. The price hit a new record peak of 170.52 and subsequently retreated, but not dramatically. Overall, the long term structure of higher highs and higher lows remains intact, keeping the pair in a clear uptrend. Weekly oscillators suggest that upside momentum is losing steam, reflecting the latest pullback in the market. The RSI has turned down after it reached its overbought levels near 70, while the MACD has flattened below its red trigger line. In case buyers take back control and pierce above the record high of 170.52, that would take the price into uncharted territory and turn the focus to round psychological numbers where traders might place their stops, providing resistance to advances. In this sense, the levels to watch would be 175.00 initially, and beyond that, the 180.00 region. Now should sellers stay in charge, the first obstacle to the downside might be the 164.50 zone, which has acted both as support and resistance in recent months. If violated, the spotlight would then shift to the 160.00 area, which halted the retreat in early October. Summarizing, the long term outlook remains clearly positive. A decisive break below 160.00 is needed to bring that into doubt, although a trend reversal would require much heavier declines than that.
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
